JAMA Health Forum
banner
jamahealthforum.com
JAMA Health Forum
@jamahealthforum.com
JAMA Health Forum is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

🌐 JAMAHealthForum.com
Public support for #Vaccines and school requirements remains high even as #VaccinePolicy changes under the new administration. ja.ma/44H6kna
December 7, 2025 at 4:00 PM
Hospital mergers may worsen facility access and quality for #Medicaid enrollees, particularly regarding #ObstetricCare and #SafetyNet hospital reliance. ja.ma/4pSNSQN
December 6, 2025 at 3:00 PM
Strict abortion bans with no health exception were linked to a rise in #EMTALA violations in obstetric emergencies and increased #ED visits for #WomensHealth. ja.ma/4pU6tff
December 5, 2025 at 4:30 PM
Yesterday, @who.int published a guideline in @jama.com on the use and indications of #GLP-1 therapies for the management of #obesity in adults. The guideline offers two conditional recommendations to inform clinical practice and health policy.

Read the guideline: ja.ma/4irQDGe
December 2, 2025 at 12:00 PM
Today, @who.int published a guideline in @jama.com on the use and indications of #GLP-1 therapies for the management of #obesity in adults.

Explore the new guideline: ja.ma/3M6d3AD
Join WHO for a public, live-streamed webinar at 10 AM ET: ja.ma/3LVuLqJ
December 1, 2025 at 3:00 PM
Analysis of matched administrative and clinical records indicated that homelessness status was underrecognized, particularly in the emergency department setting where odds of missed homelessness were nearly three times higher than in admissions.

ja.ma/4oiTz9p
November 29, 2025 at 3:00 PM
On December 1 at 10 AM ET, JAMA and JAMA Network Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, will co-chair a public, live-streamed webinar discussing a new @who.int guideline concerning #GLP-1 therapy and adults with #obesity.

Register for the webinar: ja.ma/4pfbXl2
November 28, 2025 at 6:36 PM
Manufacturer-reported costs for breakthrough-designated medical devices exceeded actual hospital acquisition costs in #Medicare supplemental reimbursement programs.

ja.ma/4rnz1PJ
November 28, 2025 at 4:00 PM
Following the 2018–2019 recalls and shortages of valsartan, losartan, and irbesartan, there were no major changes in medication adherence or drug spending in the 18 months.

ja.ma/4oWIBHP
November 27, 2025 at 4:00 PM
On December 1 at 10 AM ET, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, will co-chair a public, live-streamed webinar discussing a new WHO guideline concerning #GLP-1 therapy and adults with #obesity.

Register for the webinar: ja.ma/48lzVnk
November 26, 2025 at 5:00 PM
After the January 2025 Los Angeles fires, respiratory and cardiovascular virtual care visits increased up to 44% among highly exposed and moderately exposed groups.

ja.ma/4omeqsD
November 26, 2025 at 5:00 PM
This national study found that US physician practices received lower payments for outpatient visits with non-Hispanic Black and Hispanic patients compared with non-Hispanic White patients, after adjusting for visit content, market, and year.

ja.ma/3Xj05lu
November 26, 2025 at 4:30 PM
Viewpoint: Eliminating funding for the National Institute of Nursing Research (NINR) would discontinue research supporting interventions for #ChronicDisease, aging and AI applications in health care.

ja.ma/3LJPHAV
November 25, 2025 at 7:39 PM
Editorial: Despite challenges in #HealthPolicy and health services research, JAMA Health Forum remains committed to publishing studies with rigorous designs and methods that inform the future direction of health care. ja.ma/4psr5uS
November 24, 2025 at 3:00 PM
System, dentist, and patient-level barriers, including perceptions of program complexity and low reimbursement, limit dentist participation in #Medicaid, restricting access to oral health care for low-income adults. ja.ma/3KcsDtT
November 23, 2025 at 3:00 PM
From 2023 to 2025, #AI adoption in health care increased, with outpatient and ambulatory organizations seeing the largest increase, though rates remained lower than in finance, education, and information services. ja.ma/3M35fQ9
November 22, 2025 at 3:00 PM
#Methadone and #buprenorphine use for #OUD among Medicaid enrollees increased from 1999 to 2020, contrary to prior reports of declining methadone use in this population. ja.ma/47V6aL2
November 21, 2025 at 5:00 PM
Pregnant residents in rural communities experience greater prevalence of pregnancy-associated conditions and face limited access to hospital-based #Obstetric care, highlighting a need for greater resources and improved access to childbirth care. ja.ma/3LQHE5m
November 21, 2025 at 4:30 PM
Viewpoint: Legislation to ban direct-to-consumer prescription drug advertising is under consideration, yet research shows benefits for treatment initiation and medication adherence. ja.ma/43CkrtE
November 17, 2025 at 1:00 PM
📢 Calling all early-career scholars!

JAMA Health Forum is accepting applications for an editorial fellow who will work closely with our statistical editors. Experience with quantitative methods, causal inference, or applied statistics is preferred.

ja.ma/4oJjO9w
November 16, 2025 at 2:00 PM
Viewpoint: Pharmaceutical companies routinely exploit patents, trade secrets, copyrights, and trademarks to delay competition, sustain high drug prices, and limit patient access to affordable medication. ja.ma/4i76FoY
November 16, 2025 at 1:00 PM
During the 12 weeks following the premiere of #TheWhiteLotus season 3, #lorazepam search rates nearly doubled, including increases in queries about acquiring the drug, while searches for other benzodiazepines remained stable.

ja.ma/3K4vkxA
November 15, 2025 at 1:00 PM
Private equity acquired 749 US home health agencies from 2006 to 2024, with activity concentrated among middle-market and megafund investors, and clustered in Florida and Texas. ja.ma/49lvRFI
November 14, 2025 at 5:00 PM
Older Black and Hispanic adults with #dementia experienced higher rates of intensive end-of-life care than their non-Hispanic White counterparts, regardless of the treating physician, finds this cohort study. ja.ma/4i6fuPQ
November 14, 2025 at 4:32 PM
Viewpoint: Rapid advances in psychedelic research and policy have created a patchwork of laws regulating access, marketing, and payment, leading to confusion, potential safety issues, and disparities in treatment. ja.ma/3Xqcsfu
November 12, 2025 at 2:00 PM